Skip to main content
. 2002 Sep;51(3):429–433. doi: 10.1136/gut.51.3.429

Figure 4.

Figure 4

Influence of duration on haemodialysis treatment on percentage prevalence of hepatitis C virus (HCV) antibodies and HCV-RNA in haemodialysis patients who were not previously transfused. *p<0.05 compared with patients on haemodialysis for less then 10 years.